Compare ZS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZS | DGX |
|---|---|---|
| Founded | 2007 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.7B | 23.1B |
| IPO Year | 2018 | 1996 |
| Metric | ZS | DGX |
|---|---|---|
| Price | $117.16 | $191.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 38 | 12 |
| Target Price | ★ $272.44 | $208.92 |
| AVG Volume (30 Days) | ★ 2.4M | 646.7K |
| Earning Date | 05-28-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 1.74% |
| EPS Growth | ★ 30.77 | 13.78 |
| EPS | N/A | ★ 8.75 |
| Revenue | N/A | ★ $11,035,000,000.00 |
| Revenue This Year | $27.83 | $7.53 |
| Revenue Next Year | $19.72 | $3.77 |
| P/E Ratio | ★ N/A | $22.63 |
| Revenue Growth | N/A | ★ 11.78 |
| 52 Week Low | $120.77 | $160.02 |
| 52 Week High | $336.99 | $213.50 |
| Indicator | ZS | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 26.93 | 37.45 |
| Support Level | N/A | $176.61 |
| Resistance Level | $164.00 | $191.91 |
| Average True Range (ATR) | 7.57 | 4.46 |
| MACD | -1.01 | -0.27 |
| Stochastic Oscillator | 8.21 | 10.95 |
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.